Cleared Traditional

K944314 - DISPOSABLE TM-E COCHGTRODE - BLSC PART ...

K944314 is an FDA 510(k) clearance for DISPOSABLE TM-E COCHGTRODE - BLSC PART ..., manufactured by Bio-Logic Systems Corp.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 492-day FDA review.

K944314 · Bio-Logic Systems Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1996
Decision
492d
Days
Class 2
Risk

K944314 is an FDA 510(k) clearance for the DISPOSABLE TM-E COCHGTRODE - BLSC PART NO. 101123. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Bio-Logic Systems Corp. (Mudelein, US). The FDA issued a Cleared decision on January 3, 1996 after a review of 492 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Bio-Logic Systems Corp. devices

FDA 510(k) Submission Details - K944314

510(k) Number K944314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 1994
Decision Date January 03, 1996
Days to Decision 492 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
344d slower than avg
Panel avg: 148d · This submission: 492d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 194
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K944314.
MODEL 1210, MEDIUM E-NET
K960873 · Physiometrix, Inc. · Apr 1996
MODEL 1240, SMALL E NET
K960885 · Physiometrix, Inc. · Apr 1996
HYDROSPOT EEG ELECTRODE MODEL 1501, HYDROSPOT LEADWIRE MODEL 1500
K960732 · Physiometrix, Inc. · Apr 1996
NEUROLOGICAL DIAGNOSTIC DEVICES
K943449 · Henley Intl. · Nov 1995
MEDI-TRAC EEG ELECTRODE
K950782 · Graphic Controls Corp. · Jun 1995
MODEL 1001, HYDRODOT(TM) NEUROMONITORING SYSTEM WITH E NET(TM) EEG INTERFACE CABLE
K946318 · Physiometrix, Inc. · Apr 1995